Exencial Wealth Advisors LLC Sells 195 Shares of Corteva, Inc. $CTVA

Exencial Wealth Advisors LLC decreased its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 5.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,167 shares of the company’s stock after selling 195 shares during the period. Exencial Wealth Advisors LLC’s holdings in Corteva were worth $236,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CTVA. Gladwyn Financial Advisors Inc. bought a new position in Corteva during the 2nd quarter valued at approximately $25,000. Maryland Capital Advisors Inc. bought a new position in shares of Corteva in the 2nd quarter worth approximately $29,000. Valley National Advisers Inc. raised its position in shares of Corteva by 85.9% in the 1st quarter. Valley National Advisers Inc. now owns 526 shares of the company’s stock worth $33,000 after acquiring an additional 243 shares in the last quarter. Richardson Capital Management LLC bought a new position in shares of Corteva in the 1st quarter worth approximately $37,000. Finally, DHJJ Financial Advisors Ltd. raised its position in shares of Corteva by 132.2% in the 2nd quarter. DHJJ Financial Advisors Ltd. now owns 527 shares of the company’s stock worth $39,000 after acquiring an additional 300 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.2%

CTVA stock opened at $63.63 on Friday. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $77.41. The company has a quick ratio of 1.23, a current ratio of 1.68 and a debt-to-equity ratio of 0.06. The firm has a market cap of $43.21 billion, a PE ratio of 31.04, a price-to-earnings-growth ratio of 1.45 and a beta of 0.76. The business has a 50 day moving average of $68.53 and a 200 day moving average of $69.04.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.31. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The company had revenue of $6.46 billion during the quarter, compared to analyst estimates of $6.26 billion. During the same quarter last year, the company earned $1.83 EPS. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis. On average, research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd were paid a dividend of $0.18 per share. The ex-dividend date was Tuesday, September 2nd. This represents a $0.72 annualized dividend and a yield of 1.1%. This is a positive change from Corteva’s previous quarterly dividend of $0.17. Corteva’s dividend payout ratio (DPR) is 35.12%.

Insider Buying and Selling

In other Corteva news, EVP Robert D. King sold 37,280 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the sale, the executive vice president directly owned 49,262 shares in the company, valued at approximately $3,655,240.40. This trade represents a 43.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

Analyst Upgrades and Downgrades

CTVA has been the subject of several research reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Corteva in a research report on Friday. Jefferies Financial Group decreased their target price on Corteva from $92.00 to $85.00 in a research report on Thursday, October 2nd. Wells Fargo & Company decreased their target price on Corteva from $83.00 to $80.00 and set an “overweight” rating for the company in a research report on Thursday, October 16th. Barclays raised Corteva from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $75.00 to $84.00 in a research report on Wednesday, August 13th. Finally, JPMorgan Chase & Co. raised Corteva from a “neutral” rating to an “overweight” rating and set a $67.00 target price for the company in a research report on Thursday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $79.94.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.